Table 3.
Adolescence (14-19 years of age) | Age adjusted OR (95% CI) |
ORa (95% CI) | ORb (95% CI) | ||
---|---|---|---|---|---|
Advanced (n= 60) | Non-PCa (n) | PCa (n) | |||
n = 1,973 | |||||
Low intake | 1,183 | 39 | 1.00 | 1.00 | 1.00 |
High intake | 730 | 21 | 0.73 (0.42-1.27) | 0.71 (0.40-1.24) | 0.67 (0.37-1.20) |
Localized (n=282) | Non-PCa (n) | PCa (n) | |||
n = 2,195 | |||||
Low intake | 1,183 | 164 | 1.00 | 1.00 | 1.00 |
High intake | 730 | 118 | 1.11 (0.86-1.44) | 1.07 (0.82-1.39) | 1.02 (0.82-1.42) |
Total (n=342) | Non-PCa (n) | PCa (n) | |||
n = 2,255 | |||||
Low intake | 1,183 | 203 | 1.00 | 1.00 | 1.00 |
High intake | 730 | 139 | 1.03 (0.81-1.31) | 0.99 (0.78-1.26) | 0.99 (0.77-1.27) |
Midlife (40-50 years of age) | Age adjusted OR (95% CI) |
ORa (95% CI) | ORb (95% CI) | ||
---|---|---|---|---|---|
Advanced (n= 63) | Non-PCa (n) | PCa (n) | |||
n = 1,979 | |||||
Low intake | 1,441 | 41 | 1.00 | 1.00 | 1.00 |
High intake | 475 | 22 | 1.45 (0.85-2.48) | 1.37 (0.79-2.37) | 1.33 (0.75-2.38) |
Localized (n=280) | Non-PCa (n) | PCa (n) | |||
n = 2,196 | |||||
Low intake | 1,441 | 205 | 1.00 | 1.00 | 1.00 |
High intake | 475 | 75 | 1.06 (0.80-1.41) | 1.01 (0.76-1.35) | 1.05 (0.78-1.43) |
Total (n=343) | Non-PCa (n) | PCa (n) | |||
n = 2,259 | |||||
Low intake | 1,441 | 246 | 1.00 | 1.00 | 1.00 |
High intake | 475 | 97 | 1.12 (0.87-1.46) | 1.07 (0.82-1.39) | 1.10 (0.83-1.44) |
Abbreviations: CI, confidence interval; OR, odds ratio
Adjustment made for birth year, age at study entry in midlife, education, family history of prostate disease, going to a physician regularly, height in midlife, BMI in midlife, and type 2 diabetes in midlife
Additional adjustments made for fish-, fish liver oil-, meat-, and milk intake